Your browser doesn't support javascript.
loading
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.
Schalck, Aislyn; Sakellariou-Thompson, Donastas; Forget, Marie-Andrée; Sei, Emi; Hughes, Tara G; Reuben, Alexandre; Bai, Shanshan; Hu, Min; Kumar, Tapsi; Hurd, Mark W; Katz, Matthew H G; Tzeng, Ching-Wei D; Pant, Shubham; Javle, Milind; Fogelman, David R; Maitra, Anirban; Haymaker, Cara L; Kim, Michael P; Navin, Nicholas E; Bernatchez, Chantale.
Affiliation
  • Schalck A; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sakellariou-Thompson D; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
  • Forget MA; Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sei E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hughes TG; Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Reuben A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hu M; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kumar T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hurd MW; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Katz MHG; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tzeng CD; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pant S; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
  • Javle M; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fogelman DR; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maitra A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Haymaker CL; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kim MP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Navin NE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernatchez C; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
Cancer Discov ; 12(10): 2330-2349, 2022 10 05.
Article in En | MEDLINE | ID: mdl-35849783
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Type: Article